Xarelto Archives - Cardiovascular News

VOYAGER

New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus aspirin following lower extremity revascularisation

7th March 2023

Data from a new presp...

Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD and PAD patients

18th October 2019

The National Institute fo...

xarelto rivaroxaban

Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients

31st July 2019

The National Institute fo...

Rivaroxaban gets FDA approval for treatment in CAD or PAD

17th October 2018

Rivaroxaban, brand na...

Bayer announces new licensed indication for use of Xarelto in patients with coronary artery disease

28th August 2018

Xarelto, co-administe...

Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary artery disease

2nd August 2018

The Committee for Medicin...

Janssen seeks approval for rivaroxaban to be used to reduce cardiac events

13th December 2017

Janssen has submitted...

ESC 2017: Rivaroxaban significantly lowers risk of stroke, cardiovascular death, and myocardial infarction in patients with coronary artery disease

4th September 2017

The COMPASS study, wh...

European Medicines Agency issues positive opinion for rivaroxaban

25th July 2017

The Committee for Medicin...

ACC 2017: Dual anti-thrombotic approach has similar risk of bleeding to dual antiplatelet therapy

27th March 2017

The GEMINI-ACS study,...

COMPASS study of rivaroxaban to end early for efficacy

9th February 2017

The phase three COMPASS t...

AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients with atrial fibrillation

18th November 2016

Two drug regimens inv...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy